Xcell Biosciences

Xcell Biosciences

Signal active

Organization

Contact Information

Overview

Xcell Biosciences is a San Francisco-based life science start-up company that is developing novel and disruptive systems for cell therapy development and production. Their proprietary technology enables fine control of primary cell phenotype and function, enabling an entirely new capability for optimizing efficacy and persistence of immune cell therapies.

About

Industries

Biotechnology, Medical, Manufacturing, Therapeutics, Health Diagnostics

Founded

2012

Employees

11-50

Headquarters locations

United States, North America

Social

N/A

Profile Resume

Xcell Biosciences headquartered in United States, North America, operates in the Biotechnology, Medical, Manufacturing, Therapeutics, Health Diagnostics sector. The company focuses on Biotechnology and has secured $4.0B in funding across 100 round(s). With a team of 11-50 employees, Xcell Biosciences is actively contributing to advancements in Biotechnology. Their latest funding round, Convertible Note - Xcell Biosciences, raised $100.0K. Discover more about their projects, partnerships, and impact on our platform.

Employees

imagePlace Brian Feth

Brian Feth

Founder & CEO

imagePlace James Lim

James Lim

CSO

Funding Rounds

Funding rounds

5

Investors

1

Lead Investors

0

Total Funding Amount

$39.6M

Details

2

Xcell Biosciences has raised a total of $39.6M in funding over 2 rounds.

Announcement dateTransaction nameNumber of InvestorsMoney raisedLead Investor
2022Early Stage Venture27.5M
2017Early Stage Venture12.0M

Investors

Xcell Biosciences is funded by 16 investors.

Investor NameLead InvestorFunding RoundPartners
Xcell Biosciences-FUNDING ROUND - Xcell Biosciences12.0M
Viking Global Investors-FUNDING ROUND - Viking Global Investors12.0M
Xcell Biosciences-FUNDING ROUND - Xcell Biosciences100.0K
Illumina Accelerator-FUNDING ROUND - Illumina Accelerator100.0K

Recent Activity

There is no recent news or activity for this profile.